Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide versus salmeterol in moderate COPD
2004-000007-18Phase 3Completed
- Sponsor
- GSK
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Seretide arm with Salmeterol arm (2 arms). Primary endpoints: Change from baseline in trough FEV1 at endpoint and Relief of dyspnoea measured by Transition Dyspnoea Index. Started May 2004; status: completed.
02
Drugs
salmeterol + fluticasonesalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-000007-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000007-18.